A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these profiles privately for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where groups with numerous of participants share comparison images, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, physicians and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.
Several professionals stated the demand for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.
Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.
Platform Response and Material Removal
According to TikTok, the service has taken down violative material and banned associated hashtags and search suggestions. The organization said it was dedicated to keeping the service secure and investing in strengthening compliance measures.
Online Trading Activities
Research also found communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, glowing reviews and detailed guides for preparing or injecting at home.
Within minutes of entering one group, a seller shared WhatsApp details, where most purchases occur. The seller sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, health issues or past usage.
Item Information and Costs
Inside these communities, messages show dark colored packages with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram said it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.
Her staff has previously seen patients injured by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to possibly serious health risks”.
